Phase 1b Interim Results: Venetoclax (ABT-199/GDC-0199) in...

Clinical Lymphoma Myeloma and Leukemia 2015 / 09 Vol. 15

Phase 1b Interim Results: Venetoclax (ABT-199/GDC-0199) in Combination with Bortezomib (BTZ) and Dexamethasone (Dex) in Relapsed/Refractory (R/R) Multiple Myeloma (MM)

Touzeau, C., Chanan-Khan, A., Roberts, A.W., Agarwal, A., Facon, T., Lebovic, D., Moreau, P., Darden, D., Morris, L., Ross, J., Salem, A., Munasinghe, W., Zhu, M., Leverson, J., Enschede, S., Humerick
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.07.568
Date:
September, 2015
File:
PDF, 79 KB
english, 2015
Conversion to is in progress
Conversion to is failed